[GlobeNewswire] - LEIDEN, The Netherlands -- Prosensa Holding N.V. , the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, today reported financial results for ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment